Mechanism of dexamethasone suppression of brain tumor-associated vascular permeability in rats: Involvement of the glucocorticoid receptor and vascular permeability factor

Journal of Clinical Investigation

Volumn 98, Issue 6, 1996, Pages 1400-1408

  Heiss, John D ^a   Papavassiliou, Efstathios ^a   Merrill, Marsha J ^a,c   Nieman, Lynnette ^b   Knightly, John J ^a   Walbridge, Stuart ^a   Edwards, Nancy A ^a   Oldfield, Edward H ^a  

^a NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^b EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

cerebral edema; glioma; mifepristone; steroids; vascular endothelial growth factor

Indexed keywords

DEXAMETHASONE; GLUCOCORTICOID RECEPTOR; VASCULOTROPIN;

ANIMAL CELL; ARTICLE; BLOOD VESSEL PERMEABILITY; BRAIN EDEMA; BRAIN TUMOR; DRUG MECHANISM; IMMUNOSUPPRESSIVE TREATMENT; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0029784688     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI118927     Document Type: Article

References (70)

1. Long, D.M. 1970. Capillary infrastructure and the blood-brain barrier in human malignant brain tumors. J. Neurosurg. 32:127-144.
2. Weissman, D.E., and S.A. Grossman. 1988. A model for quantitation of peritumoral brain edema. J. Neurosci. Methods. 23:207-210.
3. Ito, U., H. Tomita, O. Tone, T. Shishido, and H. Hayashi. 1990. Formation and resolution of white matter oedema in various types of brain tumors. Acta Neurochir. Suppl. 51:149-151.
4. Aaslid, R., U. Groger, C.S. Patlak, J.D. Fenstermacher, P. Huber, and H.-J. Keulen. 1990. Fluid flow rates in human peritumoral oedema. Acta Neurochir. Suppl. 51:152-154.
5. French, L.A., and J.H. Galicich. 1962. The use of steroids for control of cerebral edema. Clin. Neurosurg. 10:212-223.
6. Ruderman, N.B., and T.C. Hall. 1965. Use of glucocorticoids in the palliative treatment of metastatic brain tumors. Cancer (Phila.). 18:298-306.
7. Ito, U., H.-J. Reulen, H. Tomita, I. Ikeda, J. Saito, and T. Maehara. 1990. A computed tomography study on formation, propagation, and resolution of edema fluid in metastatic brain tumors. Adv. Neurol. 52:459-468.
8. Weissman, D.E., D. Dufer, V. Vogel, and M.D. Abeloff. 1987. Corticosteroid toxicity in neuro-oncology patients. J. Neuro-Oncol. 5:125-128.
9. Axelrod, L. 1989. Glucocorticoids. In Textbook of Rheumatology. W.N. Kelley, E.D. Harris, Jr., S. Ruddy, and C.B. Sledge, editors. W.B. Saunders Co., Philadelphia. 845-861.
10. Weissmann, G., G. Sessa, and S. Weissmann. 1966. The action of steroids and Triton X-100 upon phospholipid/cholesterol structures. Biochem. Pharmacol. 15:1537-1551.
11. Bingham, W.G., Jr., S.E. Paul, and K.S.S. Sastry. 1971. Effect of steroid on enzyme response to cold injury in rat brain. Neurology. 21:111-121.
12. Weissmann, G. 1973. Effects of corticosteroids on the stability and fusion of biomembranes. In Asthma. K.F. Austen and L.M. Lichtenstein, editors. Academic Press Inc., New York. 221-233.
13. Hall, E.D., J.M. McCall, R.L. Chase, P.A. Yonkers, and J.M. Braughler. 1987. A nonglucocorticoid steroid analog of methylprednisolone duplicates its high-dose pharmacology in models of central nervous system trauma and neuronal membrane damage. J. Pharmacol. Exp. Ther. 242:137-142.
14. Hall, E.D., and M.A. Travis, 1988. Inhibition of arachidonic acid-induced vasogenic brain edema by the non-glucocorticoid 21-aminosteroid U74006F. Brain Res. 451:350-352.
15. McIntosh, T.K., M. Banbury, D. Smith, and M. Thomas, 1990. The novel 21-aminosteroid U-74006F attenuates cerebral oedema and improves survival after brain injury in the rat. Acta Neurochir. Suppl. 51:329-330.
16. Audus, K.L., F.L. Guillot, and J.M. Braughler. 1991. Evidence for 21-aminosteroid association with the hydrophobic domains of brain microvessel endothelial cells. Free Radical Biol. Med. 11:361-371.
17. Senger, D.R., S.J. Galli, A.M. Dvorak, C.A. Perruzzi, V.S. Garvey, and H.F. Dvorak. 1983. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science (Wash. DC). 219:983-985.
18. Dvorak, H.F., T.M. Sioussat, L.F. Brown, B. Berse, J.A. Nagy, A. Sotrel, E.J. Manseau, L. Van de Water, and D.R. Senger. 1991. Distribution of vascular permeability factor (vascular endothelial growth factor) in tumors: concentration in tumor blood vessels. J. Exp. Med. 174:1275-1278.
19. Bruce, J.N., G.R. Criscuolo, M.J. Merrill, R.R. Moquin, J.B. Blacklock, and E.H. Oldfield. 1987. Vascular permeability induced by protein product of malignant brain tumors: inhibition by dexamethasone. J. Neurosurg. 67:880-884.
20. Berkman, R.A., M.J. Merrill, W.C. Reinhold, W.T. Monacci, A. Saxena, W.C. Clark, J.T. Robertson, I.U. Ali, and E.H. Oldfield. 1993. Expression of the vascular permeability factor/vascular endothelial growth factor gene in central nervous system neoplasms. J. Clin. Invest. 91:153-159.
21. Shweiki, D., A. Itin, D. Soffer, and E. Keshet. 1992. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature (Lond.). 359:843-845.
22. Plate, K.H., G. Breier, B. Millauer, A. Ullrich, and W. Risau. 1993. Upregulation of vascular endothelial growth factor and its cognate receptors in a rat glioma model of tumor angiogenesis. Cancer Res. 53:5822-5827.
23. Goldman, C.K., J. Kim, W.-L. Wong, V. King, T. Brock, and G.Y. Gillespie. 1993. Epidermal growth factor stimulates vascular endothelial growth factor production by human malignant glioma cells: a model of glioblastoma multiforme pathophysiology. Mol. Biol. Cell. 4:121-133.
24. Criscuolo, G.R., P.I. Lelkes, D. Rotrosen, and E.H. Oldfield. 1989. Cytosolic calcium changes in endothelial cells induced by a protein product of human gliomas containing vascular permeability factor activity. J. Neurosurg. 71: 884-891.
25. King, W.A., K.L. Black, K. Ikezaki, S. Conklin, and D.P. Becker. 1991. Tumor-associated neurological dysfunction prevented by lazaroids in rats J. Neurosurg. 74:112-115.
26. Conn, G., M.L. Bayne, D.D. Soderman, P.W. Kwok, K.A. Sullivan, T.M. Palisi, D.A. Hope, and K.A. Thomas. 1990. Amino acid and cDNA sequences of a vascular endothelial cell mitogen that is homologous to platelet-derived growth factor. Proc. Natl. Acad. Sci. USA. 87:2628-2632.
27. Groothuis, D.R., J.M. Fischer, N.A. Vick, and D.D. Bigner. 1981. Comparative permeability of different glioma models to horseradish peroxidase. Cancer Treat. Rep. 65(Suppl. 2): 13-18.
28. Groothuis, D.R., J.M. Fischer, G. Lapin, D.D. Bigner, and N.A. Vick. 1982. Permeability of different experimental brain tumor models to horseradish peroxidase. J. Neuropathol. Exp. Neurol. 41:164-185.
29. Arbit, E., A. Rubinstein, G. DiResta, J. Lee, F. Ali, and J.H. Galicich. 1990. The effect of the aminosteroid U-78517G on peritumoural brain oedema. Acta Neurochir. Suppl. 51:158-159.
30. Rajan, S.S., L. Rosa, J. Francisco, A. Muraki, M. Carvlin, and E. Tuturea. 1990. MRI characterization of 9L-glioma in rat brain at 4.7 tesla. Magn. Reson. Imaging. 8:185-190.
31. Tamargo, R.J., A.K. Sills, Jr., C.S. Reinhard, M.L. Pinn, D.M. Long, and H. Brem. 1991. Interstitial delivery of dexamethasone in the brain for the reduction of peritumoral edema. J. Neurosurg. 74:956-961.
32. Vecht, C.J., A. Hovestadt, H.B.C. Verbiest, J.J. van Vliet, and W.L.J. van Putten. 1994. Dose-effect relationship of dexamethasone on Karnofsky performance in metastatic brain tumors: a randomized study of doses of 4, 8, and 16 mg per day. Neurology. 44:675-680.
33. Gerber, A.M., and E.R. Savolaine. 1980. Modification of tumor enhancement and brain edema in computerized tomography by corticosteroids: case report. Neurosurgery (Baltim.). 6:282-284.
34. 82Rb: the effect of dexamethasone and whole-brain radiation therapy. Ann. Neurol. 18:636-646.
35. Bodsch, W., T. Rommel, B.G. Ophoff, and J. Menzel. 1987. Factors responsible for the retention of fluid in human tumor edema and the effect of dexamethasone. J. Neurosurg. 67:250-257.
36. 82Rb: a positron emission tomographic study. Ann. Neurol. 25:239-245.
37. Udaka, K., Y. Takeuchi, and H.Z. Movat. 1970. Simple method for quantitation of enhanced vascular permeability. Proc. Soc. Exp. Biol. Med. 133: 1384-1387.
38. Harlow, E., and D. Lane. 1988. Immunizations. In Antibodies: A Laboratory Manual, E. Harlow and D. Lane, editors. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY. 53-138.
39. Chomczynski, P., and N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:156-159.
40. Monacci, W.T., M.J. Merrill, and E.H. Oldfield. 1993. Expression of vascular permeability factor/vascular endothelial growth factor in normal rat tissues. Am. J. Physiol. (Cell Physiol.) 264:995-1002.
41. Bacic, M., N.A. Edwards, and M.J. Merrill. 1995. Differential expression of vascular endothelial growth factor (vascular permeability factor) forms in rat tissues. Growth Factors. 12:11-15.
42. Weizsaecker, M., D.F. Deen, M.L. Rosenblum, T. Hoshino, P.H. Gutin, and M. Barker. 1981. The 9L rat brain tumor: description and application of an animal model. J. Neurol. 224:183-192.
43. Hiesiger, E.M., R.M. Voorhies, G.A. Basler, L.E. Lipschutz, J.B. Posner, and W.R. Shapiro. 1986. Opening the blood-brain and blood-tumor barriers in experimental rat brain tumors: the effect of intracarotid hyperosmolar mannitol on capillary permeability and blood flow. Ann. Neurol. 19:50-59.
44. 14C in awake cats. J. Appl. Physiol. 27:296-300.
45. Laue, L., S. Kawai, D.D. Brandon, D. Brightwell, K. Barnes, R.A. Knazek, D.L. Loriaux, and G.P. Chrousos. 1988. Receptor-mediated effects of glucocorticoids on inflammation: enhancement of the inflammatory response with a glucocorticoid antagonist. J. Steroid Biochem. 29:591-598.
46. Chrousos. G.P., L. Laue, L.K. Nieman, S. Kawai, R.U. Udelsman, D.D. Brandon, and D.L. Loriaux. 1988. Glucocorticoids and glucocorticoid antagonists: lessons from RU 486. Kidney Int. 34:18-23.
47. Iijima, K., N. Yoshikawa, D.T. Connolly, and H. Nakamura. 1993. Human mesangial cells and peripheral blood mononuclear cells produce vascular permeability factor. Kidney Int. 44:959-966.
48. Finkenzeller, G., A. Technau, and D. Marme. 1995. Hypoxia-induced transcription of the vascular endothelial growth factor gene is independent of functional AP-1 transcription factor. Biochem. Biophys. Res. Commun. 208: 432-439.
49. Ross, R., E.W. Raines, and D.F. Bowen-Pope. 1986. The biology of platelet-derived growth factor. Cell. 46:155-169.
50. Westermark, B., C.-H. Heldin, and M. Nistér. 1995. Platelet-derived growth factor in human glioma. Glia. 15:257-263.
51. Plate, K.H., G. Breier, H.A. Weich, and W. Risau. 1992. Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo. Nature (Lond.). 359:845-848.
52. Blasberg, R.G., C.S. Patlak, J.W. Jehle, and J.D. Fenstermacher. 1978. An autoradiographic technique to measure the permeability of normal and abnormal brain capillaries. Neurology. 28:363.
53. Alexander, J.T., S.C. Saris, and E.H. Oldfield. 1989. The effect of interleukin-2 on the blood-brain barrier in the 9L gliosarcoma rat model. J. Neurosurg. 70:92-96.
54. Guerin, C., J.E.A. Wolff, J. Laterra, L.R. Drewes, H. Brem, and G.W. Goldstein. 1992. Vascular differentiation and glucose transporter expression in rat gliomas: effects of steroids. Ann. Neurol. 31:481-487.
55. Plate, K.H., G. Breier, H.A. Weich, H.D. Mennel, and W. Risau. 1994. Vascular endothelial growth factor and glioma angiogenesis: coordinate induction of VEGF receptors, distribution of VEGF protein and possible in vivo regulatory mechanisms. Int. J. Cancer. 59:520-529.
56. Tischer, E., R. Mitchell, T. Hartman, M. Silva, D. Gospodarowicz, J.C. Fiddes, and J.A. Abraham. 1991. The human gene for vascular endothelial growth factor. J. Biol. Chem. 266:11947-11954.
57. Dolecki, G.J., and D.T. Connolly. 1991. Effects of a variety of cytokines and inducing agents on vascular permeability factor mRNA levels in U937 cells. Biochem. Biophys. Res. Commun. 180:572-578.
58. Jonat, C., H.J. Rahmsdorf, K.-K. Park, A.C.B. Cato, S. Gebel, H. Ponta, and P. Herrlich. 1990. Antitumor promotion and antiinflammalion: down-modulation of AP-1 (Fos/Jun) activity by glucocorticoid hormone. Cell. 62:1189-1204.
59. Schüle, R., P. Rangarajan, S. Kliewer, L.J. Ransone, J. Bolado, N. Yang, I.M. Verma, and R.M. Evans. 1990. Functional antagonism between oncoprotein c-Jun and the glucocorticoid receptor. Cell. 62:1217-1226.
60. Shima, D.T., U. Deutsch, and P.A. D'Amore. 1995. Hypoxic induction of vascular endothelial growth factor (VEGF) in human epithelial cells is mediated by increases in mRNA stability. FEBS Lett. 370:203-208.
61. Ikeda, E., M.G. Achen, G. Breier, and W. Risau. 1995. Hypoxia-induced transcriptional activation and increased mRNA stability of vascular endothelial growth factor in C6 glioma cells. J. Biol. Chem. 270:19761-19766.
62. Goldberg, M.A., and T.J. Schneider. 1994. Similarities between the oxygen-sensing mechanisms regulating the expression of vascular endothelial growth factor and erythropoietin. J. Biol. Chem. 269:4355-4359.
63. Hermanson, M., K. Funa, M. Hartman, L. Claesson-Welsh, C.-H. Heldin, B. Westermark, and M. Nistér. 1992. Platelet-derived growth factor and its receptors in human glioma tissue: expression of messenger RNA and protein suggests the presence of autocrine and paracrine loops. Cancer Res. 52:3213-3219.
64. Stewart, P.A., and M.J. Wiley. 1981. Developing nervous tissue induces formation of blood-brain barrier characteristics in invading endothelial cells: a study using quail-chick transplantation chimeras. Dev. Biol. 84:183-192.
65. Wolff, J.A. E., J. Laterra, and G.W. Goldstein. 1992. Steroid inhibition of neural microvessel morphogenesis in vitro: receptor mediation and astroglial dependence. J. Neurochem. 58:1023-1032.
66. Miller, A.H., R.L. Spencer, M. Pulera, S. Kang, B.S. McEwen, and M. Stein. 1992. Adrenal steroid receptor activation in rat brain and pituitary following dexamethasone: implications for the dexamethasone suppression test. Biol. Psychiatry. 32:850-869.
67. Megyesi, J.F., C.L. Farrell, and R.F. Del Maestro. 1990. Investigation of an inhibitor of lipid peroxidation U74006F on tumor growth and protein extravasation in the C6 astrocytoma spheroid implantation glioma model. J. Neuro-Oncol. 8:133-137.
68. Ikeda, Y., and D.M. Long. 1990. Oxygen free radicals in the genesis of peritumoural brain oedema in experimental malignant brain tumours. Acta Neurochir. Suppl. 51:142-144.
69. Tamargo, R.J., K.W. Leong, and H. Brem. 1990. Growth inhibition of the 9L glioma using polymers to release heparin and cortisone acetate. J. Neuro-Oncol. 9:131-138.
70. Green, S.B., D.P. Byar, M.D. Walker, D.A. Pistenmaa, E. Alexander, Jr., U. Batzdorf, W.H. Brooks, W.E. Hunt, J. Mealey, Jr., G.L. Odom, et al. 1983: Comparisons of carmustine, procarbazine, and high-dose methylprednisolone as additions to surgery and radiotherapy for the treatment of malignant glioma. Cancer Treat. Rep. 67:121-132.